ACTUAL TIME TOTAL ASSETS– since 4/28/17
$ 3.2 B
In 2005, Thomas Struengmann and also his twin bro, Andreas, who with each other started generic medicine manufacturer Hexal AG in 1986, sold the business (together with their 68% stake in U.S.-based Years Labs) to Novartis for $7.5 billion. Ever since, they have actually been actively investing in biotechnology and pharmaceutical companies. Their holdings additionally consist of a personal financial institution, Stuttgart-based Sudwestbank. In 2008, they developed a neuroscience research center in Frankfurt named after their dad, Ernst Struengmann. After getting a business degree from the College of Augsburg, Thomas worked as manager for the United States pharmaceutical firm Schering-Plough. Like his brother, he is stated to be an achieved golf player and also likes to . He accumulates modern-day art and Swiss watches.
It is according to Forbes.